August 21, 2024
Critics of GLP-1 therapies often portray those who use these medications as opting for an easy way out to achieve thinness, perpetuating longstanding biases like those historically associated with bariatric surgery (Heitmann, 2025)
Glucagon-like peptide 1 receptor agonists, diabetic retinopathy and angiogenesis: the AngioSafe Type 2 Diabetes Study
Step 2: Emotional Testimonials and Pseudo-Science Once on the product page, youre hit with: Fake user stories (I lost 10 kg in 4 weeks without exercise) Stock photos passed off as real customers Screenshots of charts showing hormone levels dropping Mentions of fake studies from major institutions These tactics are designed to build credibility and override skepticism
GLP-1, Mast Cells, and Immune Response: In addition to their role in pancreatic insulin secretion, GLP-1 receptors are found in certain types of immune cells, including T cells and macrophages.[ref] This is an interesting link between metabolic health and immune health, and microdosing GLP-1 medications is being looked at for preventing immune dysregulation in aging
An understudied population Drugs like Ozempic, Wegovy and Zepbound are "glucagon-like peptide-1 receptor agonists," or GLP-1s, for short